71 related articles for article (PubMed ID: 9118027)
1. Selective decrease of serum immunoglobulin G1 as a marker of malignant transformation in colorectal tissue.
Schauenstein E; Rabl H; Steinschifter W; Hirschmann C; Estelberger W; Schauenstein K
Cancer; 1997 Apr; 79(8):1482-6. PubMed ID: 9118027
[TBL] [Abstract][Full Text] [Related]
2. Selective decrease in serum immunoglobulin G1. A tissue nonspecific tumor marker detecting early stages of gynecologic malignant disease with high efficiency.
Schauenstein E; Lahousen M; Weblacher M; Steinschifter W; Estelberger W; Schauenstein K
Cancer; 1996 Aug; 78(3):511-6. PubMed ID: 8697398
[TBL] [Abstract][Full Text] [Related]
3. [Quantitative changes in the immunoglobulin G subclass system--a reliable tumor marker in squamous epithelial carcinoma in the area of the head-neck].
Anderhuber W; Steinschifter W; Gotschuli A; Schauenstein E; Schauenstein K
Laryngorhinootologie; 1998 Oct; 77(10):564-8. PubMed ID: 9842520
[TBL] [Abstract][Full Text] [Related]
4. The IgG1/G2 subclass shift--a sensitive, tissue non-specific marker for malignancy. Diagnostic performance with squamous cell carcinoma of the head and neck.
Anderhuber W; Steinschifter W; Schauenstein E; Gotschuli A; Habermann W; Fischer M; Felsner P; Schauenstein K
Br J Cancer; 1999 Apr; 79(11-12):1777-81. PubMed ID: 10206292
[TBL] [Abstract][Full Text] [Related]
5. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
[TBL] [Abstract][Full Text] [Related]
6. [Detection of serum p53 antibodies in colorectal cancer patients and the clinical significance of postoperative monitoring].
Takeda A; Shimada H; Nakajima K; Imaseki H; Okazumi S; Takayama W; Hayashi H; Iwasaki K; Sasagawa S; Chou A; Natsume T; Kouno T; Kondou S; Maeda T; Hori S; Suzuki T; Ochiai T; Isono K
Gan To Kagaku Ryoho; 1999 Dec; 26(14):2189-94. PubMed ID: 10635303
[TBL] [Abstract][Full Text] [Related]
7. [Immunoreactivity in colorectal cancer. Approaches for an immunologic diagnosis?].
Muhrer KH; Kahle M; Pasurka B
Schweiz Med Wochenschr; 1983 Apr; 113(15):546-7. PubMed ID: 6857208
[TBL] [Abstract][Full Text] [Related]
8. Selective reduction of anti-Helicobacter pylori IgG subclass antibody in gastric carcinoma.
Ren Z; Borody T; Pang G; Li LC; Dunkley M; Clancy R
J Gastroenterol Hepatol; 2005 Sep; 20(9):1338-43. PubMed ID: 16105118
[TBL] [Abstract][Full Text] [Related]
9. Response of IgG1 and IgG2 subclasses to Helicobacter pylori in subjects with chronic inflammation of the gastric mucosa, atrophy and gastric cancer in a country with high Helicobacter pylori infection prevalence.
Vorobjova T; Ren Z; Dunkley M; Clancy R; Maaroos HI; Labotkin R; Kull K; Uibo R
APMIS; 2006 May; 114(5):372-80. PubMed ID: 16725014
[TBL] [Abstract][Full Text] [Related]
10. Cathepsin D and carcino-embryonic antigen in serum, urine and tissues of colon adenocarcinoma patients.
Szajda SD; Snarska J; Jankowska A; Roszkowska-Jakimiec W; Puchalski Z; Zwierz K
Hepatogastroenterology; 2008; 55(82-83):388-93. PubMed ID: 18613372
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of vasoactive intestinal peptide (VIP) in patients with adenocarcinomas of the gastrointestinal tract.
Hejna M; Hamilton G; Brodowicz T; Haberl I; Fiebiger WC; Scheithauer W; Virgolini I; Köstler WJ; Oberhuber G; Raderer M
Anticancer Res; 2001; 21(2A):1183-7. PubMed ID: 11396161
[TBL] [Abstract][Full Text] [Related]
12. [Utility of IgG subclasses in the diagnosis and follow up of hydatidosis].
Güerri ML; Dávila M; Rodríguez M; Nieto FJ; Ladrón de Guevara C
Enferm Infecc Microbiol Clin; 2000; 18(6):262-6. PubMed ID: 11075481
[TBL] [Abstract][Full Text] [Related]
13. Immunoglobulins intrinsic to colorectal carcinoma: an unfavorable prognostic association with IgM.
Jones SL; Pihl E; Cuthbertson AM; Hughes ES; Johnson WR; Rollo AJ
J Natl Cancer Inst; 1983 Sep; 71(3):469-72. PubMed ID: 6577222
[TBL] [Abstract][Full Text] [Related]
14. Testing for anti-p53 antibodies increases the diagnostic sensitivity of conventional tumor markers.
Müller M; Meyer M; Schilling T; Ulsperger E; Lehnert T; Zentgraf H; Stremmel W; Volkmann M; Galle PR
Int J Oncol; 2006 Oct; 29(4):973-80. PubMed ID: 16964393
[TBL] [Abstract][Full Text] [Related]
15. Increased serum level of sialyl Lewis(x) antigen in blood from the tumor drainage vein in patients with non-polypoid growth type of colorectal cancer.
Nakagoe T; Sawai T; Tsuji T; Jibiki M; Ohbatake M; Nanashima A; Yamaguchi H; Kurosaki N; Yasutake T; Ayabe H; Arisawa K
J Exp Clin Cancer Res; 2001 Mar; 20(1):85-90. PubMed ID: 11370835
[TBL] [Abstract][Full Text] [Related]
16. Serum IgG1 and IgG2 antibody responses to Porphyromonas gingivalis in patients with periodontitis.
Booth V; Solakoglu O; Bavisha N; Curtis MA
Oral Microbiol Immunol; 2006 Apr; 21(2):93-9. PubMed ID: 16476018
[TBL] [Abstract][Full Text] [Related]
17. Significance of serum immunoglobulin G for leukocytosis and prognosis in childhood B-lineage acute lymphoblastic leukemia.
Potapnev MP; Belevtsev MV; Bortkevich LG; Grinev VV; Martsev SP; Kravchuk ZI; Migal NV; Aleinikova OV
Pediatr Blood Cancer; 2004 May; 42(5):421-6. PubMed ID: 15049013
[TBL] [Abstract][Full Text] [Related]
18. Using a combination of cytochrome P450 1B1 and beta-catenin for early diagnosis and prevention of colorectal cancer.
Chang H; Su JM; Huang CC; Liu LC; Tsai CH; Chou MC; Lin P
Cancer Detect Prev; 2005; 29(6):562-9. PubMed ID: 16289386
[TBL] [Abstract][Full Text] [Related]
19. Soluble CD44: quantification and molecular repartition in plasma of patients with colorectal cancer.
Masson D; Denis MG; Denis M; Blanchard D; Loirat MJ; Cassagnau E; Lustenberger P
Br J Cancer; 1999 Aug; 80(12):1995-2000. PubMed ID: 10471052
[TBL] [Abstract][Full Text] [Related]
20. Identification of nicotinamide N-methyltransferase as a novel serum tumor marker for colorectal cancer.
Roessler M; Rollinger W; Palme S; Hagmann ML; Berndt P; Engel AM; Schneidinger B; Pfeffer M; Andres H; Karl J; Bodenmüller H; Rüschoff J; Henkel T; Rohr G; Rossol S; Rösch W; Langen H; Zolg W; Tacke M
Clin Cancer Res; 2005 Sep; 11(18):6550-7. PubMed ID: 16166432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
